X linked subcortical laminar heterotopia and lissencephaly syndrome (XSCLHI LIS) is an intriguing disorder of cortical development, which causes classical lissencephaly with severe mental retardation and epilepsy in hemizygous males, and subcortical laminar heterotopia (SCLH) associated with milder mental retardation and epilepsy in heterozygous females.
X linked subcortical laminar heterotopia and lissencephaly syndrome (XSCLHI LIS) is an intriguing disorder of cortical development, which causes classical lissencephaly with severe mental retardation and epilepsy in hemizygous males, and subcortical laminar heterotopia (SCLH) associated with milder mental retardation and epilepsy in heterozygous females.
Here we report an exclusion mapping study carried out in three unrelated previously described families in which males are affected with lissencephaly and females with SCLH, using 38 microsatellite markers evenly distributed on the X chromosome. Most of the X chromosome was excluded and potential intervals of assignment in Xq22.3-q23 or in Xq27 are reported. Although the number of informative meioses did not allow a decision between these two loci, it is worth noting that the former interval is compatible with the mapping of a breakpoint involved in a de novo X;autosomal balanced translocation 46,XX,t(X;2) (q22;p25) previously described in a female with classical lissencephaly. In addition, haplotype inheritance in two families showed a grandpaternal origin of the mutation and suggested in one family the presence of mosaicism in germline cells of normal transmitfing males. (JMed Genet 1997; 34:177-183) Keywords: lissencephaly; subcortical laminar heterotopia; X inheritance.
Malformations of cortical development are an important cause of mental retardation and epilepsy. The recent widespread clinical use of magnetic resonance imaging (MRI) has enhanced the recognition and classification of this large and heterogeneous group of cortical dysgenesis, which can result from a failure of proliferation, migration, or organisation of neuronal and glial cells in the developing cortex.' Cortical dysgenesis such as lissencephaly and subcortical laminar heterotopia (SCLH), also called band heterotopia or double cortex, are frequently if not always of genetic origin. Subcortical laminar heterotopia (SCLH) consists of bilateral extensive plates of heterotopic grey matter located between the cortex and the cerebral ventricles. Clinical manifestations are mainly epilepsy and mental retardation. 2 The relative thickness of the heterotopic band correlates with the phenotype, as patients with thicker bands have more severe mental retardation and seizures.' 3 Furthermore, various thicknesses of SCLH may be observed in the same family.4 A "forme fruste" of SCLH consisting of bilateral and symmetrical bands with a regional distribution has been described.5 Lissencephaly, also called agyriapachygyria, is defined by the absence or a decrease of surface convolutions associated with a disorganisation of the layers of the cortex. The main clinical features associated with lissencephaly are profound mental retardation and epilepsy with many types of seizure.6 Various types of lissencephaly have been described; type I or "classical" lissencephaly includes both the Miller-Dieker syndrome (MDS), which comprises lissencephaly and a characteristic facial dysmorphism, and isolated lissencephaly sequence (ILS) without the striking facial appearance. CD)
Genetic distance (cM) karyotype is normal. The MRI exhibits a band of heterotopia extending from the frontal to the parietal regions. The Clinical homogeneity in the three families reported here was suggested on the following criteria. In each family, males are affected with lissencephaly, severe mental retardation, and epilepsy, while females have SCLH and mild mental impairment. Also, a common feature shared by families 2 and 3 is a worsening of the thickness of the heterotopic band and clinical phenotype in daughters compared with their mother. In family 2, II.2 has borderline intellectual function, no epilepsy, and subcortical laminar heterotopia localised in the frontal lobes. Unlike their mother, III.1 and III.2 have mental retardation and an extended band of thick heterotopic grey matter. In family 3, in contrast to her mother, III.3 is mentally retarded, hyperkinetic, and microcephalic, with extended and thick SCLH. In family 3, in addition to these common features, atypical clinical and radiological features were observed in I1.10 and III.8. Since these atypical forms are difficult to classify as true SCLH on the basis of available data generated by an extensive investigation, these subjects were not scored for linkage analysis and only the nuclear family F3 (subjects II.2, II.3, III.3, and III.4) was taken into account in the following results section. However, genotyping of the extended family 3 showed interesting data that will be discussed in the last section.
LINKAGE DATA Thirty eight informative markers spanning the X chromosome were tested for exclusion mapping. Alrmost the whole X chromosome was excluded, except two intervals shared by the three families, in Xq22.2-q23 and in Xq27. Results of a two point linkage analysis, achieved on unambiguous subjects with full penetrance for heterozygous females and hemizygous males, indicated potential linkage between the disease and marker DXS1059 in Xq22.3 with a lod score Z=2.11 at 0=0, above the critical value Z=2 that is considered as significant for a candidate chromosome2' (table   1) . Flanking markers DXS8020 in Xq22.2 and DXS 1072 in Xq23 defined a 9.2 cM candidate region. Another positive, but non-significant lod score was found for marker DXS8084 (Z=1.45, 0=0) in Xq27. However, haplotype analysis of families 2 and 3 indicates that at the candidate Xq22 region and also at Xq27, all affected children share alleles inherited from their healthy grandfather ( fig IA) . Indeed, using multipoint linkage analysis, we observe a dramatic decrease of the maximum lod score at DXS 1059 (Z= 1.1 at 0=0) and the Xq27 region was ruled out (fig 2, first (1) the greatly predominant occurrence of sporadic SCLH in females, '4 16 (2) in familial forms, only males exhibit major brain malformations with lissencephaly and females express exclusively mild phenotypes with SCLH, (3) in family 2, a woman with SCLH has two daughters with SCLH and a son with lissencephaly, each by a different father, (4) no male to male transmission has ever been described, (5) a girl described by Dobyns et atr had lissencephaly and a de novo X;2 translocation. If we hypothesise that lissencephaly observed in hemizygous males results from the absence of the functioning gene in all cells and SCLH observed in females results from mosaicism related to the random inactivation of the X chromosomes, the unusually severe phenotype (lissencephaly) associated with this translocation could result from the non-random inactivation of the normal X chromosome, therefore leading to complete inactivation of both alleles in most cells.
The preliminary molecular study'4 of this apparently balanced, de novo, X;autosome translocation, 46,XX,t(X;2) (q22;p25), showed that the breakpoint is distal to marker DXS87 (fig 3) , which suggested a localisation of the XSCLH/LIS gene at Xq22.3. Here we report an exclusion mapping study performed on a homogeneous population of families with XSCLH/LIS syndrome. Our results showed a potential location of the XSCLH/LIS locus either in Xq22.3-q23, between DXS8020 and DXS1072, or in Xq27 (figs 2 and 4). Though the latter region was not excluded, the compatibility between the mapping of the breakpoint involved in the X;2 balanced translocation ( fig  4) and the interval of assignment in Xq22 strongly suggests that the region defined within Xq22.3-q23 is the likely locus for XSCLH/ LIS.
The absence of overlap between the regions defined in this study and the recently reported locus in Xq28 (interval of 7 cM between DXS1113 and the telomere) for bilateral periventricular nodular heterotopia (BPNH) syndrome" enabled us to rule out that these two X linked cortical malformations are allelic forms of the same gene (fig 4) . 
